Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The apoptotic effect of 1'S-1'-Acetoxychavicol Acetate (ACA) enhanced by inhibition of non-canonical autophagy in human non-small cell lung cancer cells.

Identifieur interne : 000178 ( PubMed/Curation ); précédent : 000177; suivant : 000179

The apoptotic effect of 1'S-1'-Acetoxychavicol Acetate (ACA) enhanced by inhibition of non-canonical autophagy in human non-small cell lung cancer cells.

Auteurs : Sophia P M. Sok [Malaisie] ; Norhafiza M. Arshad [Malaisie] ; Mohamad Nurul Azmi [Malaisie] ; Khalijah Awang [Malaisie] ; Bulent Ozpolat [États-Unis] ; Noor Hasima Nagoor [Malaisie]

Source :

RBID : pubmed:28158287

Descripteurs français

English descriptors

Abstract

Autophagy plays a role in deciding the fate of cells by inducing either survival or death. 1'S-1-acetoxychavicol acetate (ACA) is a phenylpropanoid isolated from rhizomes of Alpinia conchigera and has been reported previously on its apoptotic effects on various cancers. However, the effect of ACA on autophagy remains ambiguous. The aims of this study were to investigate the autophagy-inducing ability of ACA in human non-small cell lung cancer (NSCLC), and to determine its role as pro-survival or pro-death mechanism. Cell viability assay was conducted using MTT. The effect of autophagy was assessed by acridine orange staining, GFP-LC3 punctate formation assay, and protein level were analysed using western blot. Annexin V-FITC/PI staining was performed to detect percentage of cells undergoing apoptosis by using flow cytometry. ACA inhibits the cell viability and induced formation of cytoplasmic vacuoles in NSCLC cells. Acidic vesicular organelles and GFP-LC3 punctate formation were increased in response to ACA exposure in A549 and SK-LU-1 cell lines; implying occurrence of autophagy. In western blot, accumulation of LC3-II accompanied by degradation of p62 was observed, which further confirmed the full flux of autophagy induction by ACA. The reduction of Beclin-1 upon ACA treatment indicated the Beclin-1-independent autophagy pathway. An early autophagy inhibitor, 3-methyaldenine (3-MA), failed to suppress the autophagy triggered by ACA; validating the existence of Beclin-1-independent autophagy. Silencing of LC3-II using short interfering RNA (siRNA) abolished the autophagy effects, enhancing the cytotoxicity of ACA through apoptosis. This proposed ACA triggered a pro-survival autophagy in NSCLC cells. Consistently, co-treatment with lysosomal inhibitor, chloroquine (CQ), exerted a synergistic effect resulting in apoptosis. Our findings suggested ACA induced pro-survival autophagy through Beclin-1-independent pathway in NSCLC. Hence, targeting autophagy pathway using autophagy inhibitor such as CQ represented a novel promising approach to potentiate the cytotoxicity of ACA through apoptosis in NSCLC.

DOI: 10.1371/journal.pone.0171329
PubMed: 28158287

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:28158287

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">The apoptotic effect of 1'S-1'-Acetoxychavicol Acetate (ACA) enhanced by inhibition of non-canonical autophagy in human non-small cell lung cancer cells.</title>
<author>
<name sortKey="Sok, Sophia P M" sort="Sok, Sophia P M" uniqKey="Sok S" first="Sophia P M" last="Sok">Sophia P M. Sok</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Biological Sciences (Genetics and Molecular Biology), Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia.</nlm:affiliation>
<country xml:lang="fr">Malaisie</country>
<wicri:regionArea>Institute of Biological Sciences (Genetics and Molecular Biology), Faculty of Science, University of Malaya, Kuala Lumpur</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Arshad, Norhafiza M" sort="Arshad, Norhafiza M" uniqKey="Arshad N" first="Norhafiza M" last="Arshad">Norhafiza M. Arshad</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Biological Sciences (Genetics and Molecular Biology), Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia.</nlm:affiliation>
<country xml:lang="fr">Malaisie</country>
<wicri:regionArea>Institute of Biological Sciences (Genetics and Molecular Biology), Faculty of Science, University of Malaya, Kuala Lumpur</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Azmi, Mohamad Nurul" sort="Azmi, Mohamad Nurul" uniqKey="Azmi M" first="Mohamad Nurul" last="Azmi">Mohamad Nurul Azmi</name>
<affiliation wicri:level="1">
<nlm:affiliation>Centre of Natural Product Research and Drug Discovery (CENAR), Department of Chemistry, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia.</nlm:affiliation>
<country xml:lang="fr">Malaisie</country>
<wicri:regionArea>Centre of Natural Product Research and Drug Discovery (CENAR), Department of Chemistry, Faculty of Science, University of Malaya, Kuala Lumpur</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Awang, Khalijah" sort="Awang, Khalijah" uniqKey="Awang K" first="Khalijah" last="Awang">Khalijah Awang</name>
<affiliation wicri:level="1">
<nlm:affiliation>Centre of Natural Product Research and Drug Discovery (CENAR), Department of Chemistry, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia.</nlm:affiliation>
<country xml:lang="fr">Malaisie</country>
<wicri:regionArea>Centre of Natural Product Research and Drug Discovery (CENAR), Department of Chemistry, Faculty of Science, University of Malaya, Kuala Lumpur</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Ozpolat, Bulent" sort="Ozpolat, Bulent" uniqKey="Ozpolat B" first="Bulent" last="Ozpolat">Bulent Ozpolat</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Hasima Nagoor, Noor" sort="Hasima Nagoor, Noor" uniqKey="Hasima Nagoor N" first="Noor" last="Hasima Nagoor">Noor Hasima Nagoor</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Biological Sciences (Genetics and Molecular Biology), Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia.</nlm:affiliation>
<country xml:lang="fr">Malaisie</country>
<wicri:regionArea>Institute of Biological Sciences (Genetics and Molecular Biology), Faculty of Science, University of Malaya, Kuala Lumpur</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28158287</idno>
<idno type="pmid">28158287</idno>
<idno type="doi">10.1371/journal.pone.0171329</idno>
<idno type="wicri:Area/PubMed/Corpus">000178</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000178</idno>
<idno type="wicri:Area/PubMed/Curation">000178</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000178</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">The apoptotic effect of 1'S-1'-Acetoxychavicol Acetate (ACA) enhanced by inhibition of non-canonical autophagy in human non-small cell lung cancer cells.</title>
<author>
<name sortKey="Sok, Sophia P M" sort="Sok, Sophia P M" uniqKey="Sok S" first="Sophia P M" last="Sok">Sophia P M. Sok</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Biological Sciences (Genetics and Molecular Biology), Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia.</nlm:affiliation>
<country xml:lang="fr">Malaisie</country>
<wicri:regionArea>Institute of Biological Sciences (Genetics and Molecular Biology), Faculty of Science, University of Malaya, Kuala Lumpur</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Arshad, Norhafiza M" sort="Arshad, Norhafiza M" uniqKey="Arshad N" first="Norhafiza M" last="Arshad">Norhafiza M. Arshad</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Biological Sciences (Genetics and Molecular Biology), Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia.</nlm:affiliation>
<country xml:lang="fr">Malaisie</country>
<wicri:regionArea>Institute of Biological Sciences (Genetics and Molecular Biology), Faculty of Science, University of Malaya, Kuala Lumpur</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Azmi, Mohamad Nurul" sort="Azmi, Mohamad Nurul" uniqKey="Azmi M" first="Mohamad Nurul" last="Azmi">Mohamad Nurul Azmi</name>
<affiliation wicri:level="1">
<nlm:affiliation>Centre of Natural Product Research and Drug Discovery (CENAR), Department of Chemistry, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia.</nlm:affiliation>
<country xml:lang="fr">Malaisie</country>
<wicri:regionArea>Centre of Natural Product Research and Drug Discovery (CENAR), Department of Chemistry, Faculty of Science, University of Malaya, Kuala Lumpur</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Awang, Khalijah" sort="Awang, Khalijah" uniqKey="Awang K" first="Khalijah" last="Awang">Khalijah Awang</name>
<affiliation wicri:level="1">
<nlm:affiliation>Centre of Natural Product Research and Drug Discovery (CENAR), Department of Chemistry, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia.</nlm:affiliation>
<country xml:lang="fr">Malaisie</country>
<wicri:regionArea>Centre of Natural Product Research and Drug Discovery (CENAR), Department of Chemistry, Faculty of Science, University of Malaya, Kuala Lumpur</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Ozpolat, Bulent" sort="Ozpolat, Bulent" uniqKey="Ozpolat B" first="Bulent" last="Ozpolat">Bulent Ozpolat</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Hasima Nagoor, Noor" sort="Hasima Nagoor, Noor" uniqKey="Hasima Nagoor N" first="Noor" last="Hasima Nagoor">Noor Hasima Nagoor</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Biological Sciences (Genetics and Molecular Biology), Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia.</nlm:affiliation>
<country xml:lang="fr">Malaisie</country>
<wicri:regionArea>Institute of Biological Sciences (Genetics and Molecular Biology), Faculty of Science, University of Malaya, Kuala Lumpur</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">PloS one</title>
<idno type="eISSN">1932-6203</idno>
<imprint>
<date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Apoptosis (drug effects)</term>
<term>Apoptosis (genetics)</term>
<term>Autophagy (drug effects)</term>
<term>Beclin-1 (metabolism)</term>
<term>Benzyl Alcohols (pharmacology)</term>
<term>Blotting, Western</term>
<term>Carcinoma, Non-Small-Cell Lung</term>
<term>Cell Line, Tumor</term>
<term>Cell Survival (drug effects)</term>
<term>Humans</term>
<term>Plant Extracts (chemistry)</term>
<term>Plant Extracts (pharmacology)</term>
<term>Plants, Medicinal (chemistry)</term>
<term>RNA Interference</term>
<term>Rhizome (chemistry)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Alcools benzyliques (pharmacologie)</term>
<term>Apoptose ()</term>
<term>Apoptose (génétique)</term>
<term>Autophagie ()</term>
<term>Bécline-1 (métabolisme)</term>
<term>Carcinome pulmonaire non à petites cellules</term>
<term>Extraits de plantes ()</term>
<term>Extraits de plantes (pharmacologie)</term>
<term>Humains</term>
<term>Interférence par ARN</term>
<term>Lignée cellulaire tumorale</term>
<term>Plantes médicinales ()</term>
<term>Rhizome ()</term>
<term>Survie cellulaire ()</term>
<term>Technique de Western</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Plant Extracts</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Beclin-1</term>
</keywords>
<keywords scheme="MESH" qualifier="chemistry" xml:lang="en">
<term>Plants, Medicinal</term>
<term>Rhizome</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Apoptosis</term>
<term>Autophagy</term>
<term>Cell Survival</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Apoptosis</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Apoptose</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Bécline-1</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Alcools benzyliques</term>
<term>Extraits de plantes</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Benzyl Alcohols</term>
<term>Plant Extracts</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Blotting, Western</term>
<term>Carcinoma, Non-Small-Cell Lung</term>
<term>Cell Line, Tumor</term>
<term>Humans</term>
<term>RNA Interference</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Apoptose</term>
<term>Autophagie</term>
<term>Carcinome pulmonaire non à petites cellules</term>
<term>Extraits de plantes</term>
<term>Humains</term>
<term>Interférence par ARN</term>
<term>Lignée cellulaire tumorale</term>
<term>Plantes médicinales</term>
<term>Rhizome</term>
<term>Survie cellulaire</term>
<term>Technique de Western</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Autophagy plays a role in deciding the fate of cells by inducing either survival or death. 1'S-1-acetoxychavicol acetate (ACA) is a phenylpropanoid isolated from rhizomes of Alpinia conchigera and has been reported previously on its apoptotic effects on various cancers. However, the effect of ACA on autophagy remains ambiguous. The aims of this study were to investigate the autophagy-inducing ability of ACA in human non-small cell lung cancer (NSCLC), and to determine its role as pro-survival or pro-death mechanism. Cell viability assay was conducted using MTT. The effect of autophagy was assessed by acridine orange staining, GFP-LC3 punctate formation assay, and protein level were analysed using western blot. Annexin V-FITC/PI staining was performed to detect percentage of cells undergoing apoptosis by using flow cytometry. ACA inhibits the cell viability and induced formation of cytoplasmic vacuoles in NSCLC cells. Acidic vesicular organelles and GFP-LC3 punctate formation were increased in response to ACA exposure in A549 and SK-LU-1 cell lines; implying occurrence of autophagy. In western blot, accumulation of LC3-II accompanied by degradation of p62 was observed, which further confirmed the full flux of autophagy induction by ACA. The reduction of Beclin-1 upon ACA treatment indicated the Beclin-1-independent autophagy pathway. An early autophagy inhibitor, 3-methyaldenine (3-MA), failed to suppress the autophagy triggered by ACA; validating the existence of Beclin-1-independent autophagy. Silencing of LC3-II using short interfering RNA (siRNA) abolished the autophagy effects, enhancing the cytotoxicity of ACA through apoptosis. This proposed ACA triggered a pro-survival autophagy in NSCLC cells. Consistently, co-treatment with lysosomal inhibitor, chloroquine (CQ), exerted a synergistic effect resulting in apoptosis. Our findings suggested ACA induced pro-survival autophagy through Beclin-1-independent pathway in NSCLC. Hence, targeting autophagy pathway using autophagy inhibitor such as CQ represented a novel promising approach to potentiate the cytotoxicity of ACA through apoptosis in NSCLC.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">28158287</PMID>
<DateCompleted>
<Year>2017</Year>
<Month>08</Month>
<Day>28</Day>
</DateCompleted>
<DateRevised>
<Year>2019</Year>
<Month>02</Month>
<Day>08</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">1932-6203</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>12</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2017</Year>
</PubDate>
</JournalIssue>
<Title>PloS one</Title>
<ISOAbbreviation>PLoS ONE</ISOAbbreviation>
</Journal>
<ArticleTitle>The apoptotic effect of 1'S-1'-Acetoxychavicol Acetate (ACA) enhanced by inhibition of non-canonical autophagy in human non-small cell lung cancer cells.</ArticleTitle>
<Pagination>
<MedlinePgn>e0171329</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0171329</ELocationID>
<Abstract>
<AbstractText>Autophagy plays a role in deciding the fate of cells by inducing either survival or death. 1'S-1-acetoxychavicol acetate (ACA) is a phenylpropanoid isolated from rhizomes of Alpinia conchigera and has been reported previously on its apoptotic effects on various cancers. However, the effect of ACA on autophagy remains ambiguous. The aims of this study were to investigate the autophagy-inducing ability of ACA in human non-small cell lung cancer (NSCLC), and to determine its role as pro-survival or pro-death mechanism. Cell viability assay was conducted using MTT. The effect of autophagy was assessed by acridine orange staining, GFP-LC3 punctate formation assay, and protein level were analysed using western blot. Annexin V-FITC/PI staining was performed to detect percentage of cells undergoing apoptosis by using flow cytometry. ACA inhibits the cell viability and induced formation of cytoplasmic vacuoles in NSCLC cells. Acidic vesicular organelles and GFP-LC3 punctate formation were increased in response to ACA exposure in A549 and SK-LU-1 cell lines; implying occurrence of autophagy. In western blot, accumulation of LC3-II accompanied by degradation of p62 was observed, which further confirmed the full flux of autophagy induction by ACA. The reduction of Beclin-1 upon ACA treatment indicated the Beclin-1-independent autophagy pathway. An early autophagy inhibitor, 3-methyaldenine (3-MA), failed to suppress the autophagy triggered by ACA; validating the existence of Beclin-1-independent autophagy. Silencing of LC3-II using short interfering RNA (siRNA) abolished the autophagy effects, enhancing the cytotoxicity of ACA through apoptosis. This proposed ACA triggered a pro-survival autophagy in NSCLC cells. Consistently, co-treatment with lysosomal inhibitor, chloroquine (CQ), exerted a synergistic effect resulting in apoptosis. Our findings suggested ACA induced pro-survival autophagy through Beclin-1-independent pathway in NSCLC. Hence, targeting autophagy pathway using autophagy inhibitor such as CQ represented a novel promising approach to potentiate the cytotoxicity of ACA through apoptosis in NSCLC.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sok</LastName>
<ForeName>Sophia P M</ForeName>
<Initials>SP</Initials>
<AffiliationInfo>
<Affiliation>Institute of Biological Sciences (Genetics and Molecular Biology), Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Arshad</LastName>
<ForeName>Norhafiza M</ForeName>
<Initials>NM</Initials>
<AffiliationInfo>
<Affiliation>Institute of Biological Sciences (Genetics and Molecular Biology), Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Centre for Research in Biotechnology for Agriculture (CEBAR), University of Malaya, Kuala Lumpur, Malaysia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Azmi</LastName>
<ForeName>Mohamad Nurul</ForeName>
<Initials>MN</Initials>
<AffiliationInfo>
<Affiliation>Centre of Natural Product Research and Drug Discovery (CENAR), Department of Chemistry, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Awang</LastName>
<ForeName>Khalijah</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Centre of Natural Product Research and Drug Discovery (CENAR), Department of Chemistry, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ozpolat</LastName>
<ForeName>Bulent</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hasima Nagoor</LastName>
<ForeName>Noor</ForeName>
<Initials>N</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0003-3905-3129</Identifier>
<AffiliationInfo>
<Affiliation>Institute of Biological Sciences (Genetics and Molecular Biology), Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Centre for Research in Biotechnology for Agriculture (CEBAR), University of Malaya, Kuala Lumpur, Malaysia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2017</Year>
<Month>02</Month>
<Day>03</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>PLoS One</MedlineTA>
<NlmUniqueID>101285081</NlmUniqueID>
<ISSNLinking>1932-6203</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000071186">Beclin-1</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001592">Benzyl Alcohols</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010936">Plant Extracts</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>SQV3080A20</RegistryNumber>
<NameOfSubstance UI="C047948">1'-acetoxychavicol acetate</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000071186" MajorTopicYN="N">Beclin-1</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001592" MajorTopicYN="N">Benzyl Alcohols</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002289" MajorTopicYN="N">Carcinoma, Non-Small-Cell Lung</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010936" MajorTopicYN="N">Plant Extracts</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010946" MajorTopicYN="N">Plants, Medicinal</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D034622" MajorTopicYN="N">RNA Interference</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D027343" MajorTopicYN="N">Rhizome</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
</MeshHeading>
</MeshHeadingList>
<CoiStatement>The authors have declared that no competing interests exist.</CoiStatement>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2016</Year>
<Month>07</Month>
<Day>22</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2017</Year>
<Month>01</Month>
<Day>18</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2017</Year>
<Month>2</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2017</Year>
<Month>2</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2017</Year>
<Month>8</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">28158287</ArticleId>
<ArticleId IdType="doi">10.1371/journal.pone.0171329</ArticleId>
<ArticleId IdType="pii">PONE-D-16-29337</ArticleId>
<ArticleId IdType="pmc">PMC5291426</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Int J Cancer. 2015 Mar 1;136(5):E359-86</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25220842</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Autophagy. 2013 Jun 1;9(6):905-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23575457</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Res. 2001 Jan 15;61(2):439-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11212227</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Treat Rev. 2008 Dec;34(8):737-49</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18722718</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Molecules. 2010 Nov 09;15(11):8048-59</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21063268</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Cancer Res. 2004 Mar 15;10(6):2120-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15041733</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Thorac Oncol. 2013 Jun;8(6):693-702</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23575415</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2015 Mar 25;10(3):e0119135</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25807554</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Death Dis. 2013 Oct 10;4:e838</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24113172</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Death Differ. 2008 Aug;15(8):1318-29</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18421301</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Res. 2014 Jan;24(1):69-79</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24323045</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Phytomedicine. 2015 Sep 15;22(10):902-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26321739</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Manag Res. 2015 Sep 11;7:291-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26392787</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2010 Aug 13;285(33):25570-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20529838</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Death Dis. 2014 Nov 06;5:e1509</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25375374</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Thorac Oncol. 2012 Oct;7(10):1602-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22878749</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Reprod Sci. 2013 May;20(5):567-78</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23012319</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Oral Biol. 2012 Aug;57(8):1018-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22554995</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncologist. 2006 Apr;11(4):342-57</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16614230</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genes Dev. 2011 Mar 1;25(5):460-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21317241</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mayo Clin Proc. 2008 May;83(5):584-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18452692</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Complement Altern Med. 2012 Oct 09;12:179</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23043547</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Autophagy. 2008 Oct;4(7):949-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18769111</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Res Treat. 2017 Jan;49(1):230-245</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27338037</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Korean J Physiol Pharmacol. 2011 Feb;15(1):1-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21461234</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Chem Biol Interact. 2014 Apr 5;212:1-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24480522</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Cancer. 2012 Dec 27;12 :622</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23270461</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Autophagy. 2012 Jul 1;8(7):1032-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22562073</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Autophagy. 2009 Aug;5(6):858-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19458474</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Toxicol Sci. 2014 Jan;137(1):65-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24154491</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Oncol. 2012 Apr;40(4):1020-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22218562</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Death Differ. 2010 Dec;17 (12 ):1867-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20508647</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncotarget. 2015 Jun 30;6(18):16151-67</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26158863</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Cancer. 2016 Jan 13;16:17</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26762417</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000178 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000178 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:28158287
   |texte=   The apoptotic effect of 1'S-1'-Acetoxychavicol Acetate (ACA) enhanced by inhibition of non-canonical autophagy in human non-small cell lung cancer cells.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:28158287" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a ChloroquineV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021